We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

475 hedge funds and large institutions have $9.94B invested in United Therapeutics in 2023 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 192 increasing their positions, 161 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more call options, than puts

Call options by funds: $22.4M | Put options by funds: $17.2M

19% more repeat investments, than reductions

Existing positions increased: 192 | Existing positions reduced: 161

2% less capital invested

Capital invested by funds: $10.1B → $9.94B (-$195M)

2.48% less ownership

Funds ownership: 98.65% → 96.18% (-2.5%)

6% less funds holding

Funds holding: 506 → 475 (-31)

18% less funds holding in top 10

Funds holding in top 10: 17 → 14 (-3)

39% less first-time investments, than exits

New positions opened: 45 | Existing positions closed: 74

Holders
475
Holders Change
-31
Holders Change %
-6.13%
% of All Funds
7.46%
Holding in Top 10
14
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-17.65%
% of All Funds
0.22%
New
45
Increased
192
Reduced
161
Closed
74
Calls
$22.4M
Puts
$17.2M
Net Calls
+$5.14M
Net Calls Change
+$7.57M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$201M
2
O
OrbiMed
New York
+$89M
3
BlackRock
BlackRock
New York
+$76.4M
4
ITP
Iron Triangle Partners
Connecticut
+$44.3M
5
AQR Capital Management
AQR Capital Management
Connecticut
+$30.4M

Top Sellers

1
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$107M
2
FCM
Farallon Capital Management
California
-$104M
3
PCH
Polar Capital Holdings
United Kingdom
-$72.6M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$44.4M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$39.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
HighTower Advisors
276
HighTower Advisors
Illinois
$737K +$500K +2,259 +208%
APF
277
Alaska Permanent Fund
Alaska
$723K +$725K +3,273 New
RI
278
Ridgewood Investments
New Jersey
$706K – – –
AI
279
Axiom Investors
Connecticut
$706K -$50.3K -227 -7%
Mariner
280
Mariner
Kansas
$682K +$40.8K +184 +6%
CS
281
Candriam SCA
Luxembourg
$659K -$1.02M -4,597 -61%
AG
282
Artal Group
Luxembourg
$656K -$68.7K -310 -9%
Daiwa Securities Group
283
Daiwa Securities Group
Japan
$655K -$3.1K -14 -0.5%
DTL
284
Dynamic Technology Lab
Singapore
$649K -$576K -2,599 -47%
Creative Planning
285
Creative Planning
Kansas
$641K +$110K +495 +21%
IIM
286
INTECH Investment Management
Florida
$628K -$262K -1,184 -29%
NYLIM
287
New York Life Investment Management
New York
$625K +$628K +2,833 New
HF
288
HRT Financial
New York
$623K -$7.28M -32,876 -92%
CL
289
CSS LLC
Illinois
$618K +$66.5K +300 +12%
HWAM
290
Hennion & Walsh Asset Management
New Jersey
$598K +$12.2K +55 +2%
VIA
291
Vident Investment Advisory
Georgia
$596K +$281K +1,267 +89%
CAM
292
Connacht Asset Management
New York
$593K +$142K +639 +31%
ETC
293
Exchange Traded Concepts
Oklahoma
$586K +$23.3K +105 +4%
Nordea Investment Management
294
Nordea Investment Management
Sweden
$572K – – –
HT
295
Headlands Technologies
Illinois
$563K +$553K +2,498 +4,898%
SGA
296
Seaport Global Advisors
Massachusetts
$562K +$97K +438 +21%
SAM
297
Shell Asset Management
Netherlands
$560K -$313K -1,413 -36%
AAM
298
Aureus Asset Management
Massachusetts
$552K – – –
Neuberger Berman Group
299
Neuberger Berman Group
New York
$540K +$117K +527 +27%
SPA
300
Sherbrooke Park Advisers
New York
$530K +$199K +900 +60%
10 11
12
13 14

UTHR Hedge Fund Activity: Q2 2023 in Review

475 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2023, worth a combined $9.94B — down 1.9% from $10.1B a quarter earlier.

Sellers outnumbered buyers: 74 funds closed out of UTHR and 45 opened new positions — a net loss of 29 holders — while 161 trimmed existing stakes and 192 added.

The largest buyer was Wellington Management Group, adding an estimated $201M. The largest seller was Envestnet Asset Management, cutting an estimated $107M.

  • 475 institutional investors held United Therapeutics (UTHR) as of Q2 2023, down from 506 in Q1 2023.
  • Funds reported $9.94B of United Therapeutics stock for Q2 2023, down 1.9% quarter-over-quarter.
  • 45 funds opened new United Therapeutics positions in Q2 2023 and 74 closed out, a net change of -29 holders.
  • The largest United Therapeutics buyer in Q2 2023 was Wellington Management Group, an estimated $201M added.
  • The largest United Therapeutics seller in Q2 2023 was Envestnet Asset Management, an estimated $107M sold.

Based on aggregated 13F filings for Q2 2023.